2024
DOI: 10.1080/10837450.2024.2410448
| |Summarize |Cite
|
Sign up to set email alerts

Challenges and recent advances in erythropoietin stability

Search citation statements

Order By: Relevance

Paper Sections

Select...
8
0
0
0

Citation Types

0
2
0
0

Year Published

Range
2025
2025
2026
2026

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

Cited by 8 publications

(2 citation statements)

References 149 publications

0
2
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…The optimization of carrier materials, encapsulation techniques, and sterilization methods are necessary to ensure prolonged bioactivity without compromising scaffold integrity. The long-term stability of EPO-loaded scaffolds, while demonstrated in preclinical settings ( Fayed et al, 2024 ), lacks human trial validation, raising concerns about polymer degradation kinetics and sustained bioactivity beyond 6 months. Safety risks remain paramount: systemic EPO use increases thromboembolism and stroke risks ( Ma et al, 2022 ; Åberg et al, 2016 ; Lippi Massimo and Favaloro Emmanuel, 2010 ; Anaissie et al, 2012 ).…”
Section: Conclusion and Future Prospects
mentioning
confidence: 99%